Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H M van Praag

Showing results (191-200 of 290) with videos related to

Pageof 29
Sort By:
PDM: Physicians' Drug Manual|January 1, 1973
An attempt at indirect evaluation of the noradrenaline hypothesisH M van Praag, T P Kits, T Schut, et al.
Acta Psychiatrica Scandinavica|May 1, 1979
Therapeutical significance of clopimozide in the treatment of chronic psychotic patientsH J De Cuyper, H M Van Praag, W R Mulder
Nature: New Biology|April 19, 1972
[Predictive value of the probenecid test for the effect of L-DOPA therapy in Parkinson's disease]J P Lakke, J Korf, H M Van Praag, et al.
Psychopharmacologia|January 1, 1972
A pilot study of the predictive value of the probenecid test in application of 5-hydroxytryptophan as antidepressantH M van Praag, J Korf, L C Dols, et al.
Psychiatria, Neurologia, Neurochirurgia|January 1, 1973
Monoamine metabolism and depression in Parkinson patientsJ K Puite, T Schut, H M van Praag, et al.
The Journal of Clinical Psychiatry|May 1, 1988
Effect of tyrosine on attention deficit disorder with hyperactivityJ Eisenberg, G M Asnis, H M van Praag, et al.
The Journal of Nervous and Mental Disease|October 1, 1990
Significance of cocaine history in schizophreniaS Sevy, S R Kay, L A Opler, et al.
Psychopharmacologia|January 1, 1971
A comparative study of the therapeutic effects of sone 4-chlorinated amphetamine derivatives in depressive patientsH M van Praag, T Schut, E Bosma, et al.
Psychopharmacology|January 1, 1988
Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorderR S Kahn, G M Asnis, S Wetzler, et al.
Acta Psychiatrica Scandinavica|July 1, 1981
Fluvoxamine and clomipramine in depressed patients. A double-blind clinical studyC J Klok, G J Brouwer, H M van Praag, et al.
Pageof 29

Showing results (191-200 of 290) with videos related to

Sort By:
Pageof 29
PDM: Physicians' Drug Manual|January 1, 1973
An attempt at indirect evaluation of the noradrenaline hypothesisH M van Praag, T P Kits, T Schut, et al.
Acta Psychiatrica Scandinavica|May 1, 1979
Therapeutical significance of clopimozide in the treatment of chronic psychotic patientsH J De Cuyper, H M Van Praag, W R Mulder
Nature: New Biology|April 19, 1972
[Predictive value of the probenecid test for the effect of L-DOPA therapy in Parkinson's disease]J P Lakke, J Korf, H M Van Praag, et al.
Psychopharmacologia|January 1, 1972
A pilot study of the predictive value of the probenecid test in application of 5-hydroxytryptophan as antidepressantH M van Praag, J Korf, L C Dols, et al.
Psychiatria, Neurologia, Neurochirurgia|January 1, 1973
Monoamine metabolism and depression in Parkinson patientsJ K Puite, T Schut, H M van Praag, et al.
The Journal of Clinical Psychiatry|May 1, 1988
Effect of tyrosine on attention deficit disorder with hyperactivityJ Eisenberg, G M Asnis, H M van Praag, et al.
The Journal of Nervous and Mental Disease|October 1, 1990
Significance of cocaine history in schizophreniaS Sevy, S R Kay, L A Opler, et al.
Psychopharmacologia|January 1, 1971
A comparative study of the therapeutic effects of sone 4-chlorinated amphetamine derivatives in depressive patientsH M van Praag, T Schut, E Bosma, et al.
Psychopharmacology|January 1, 1988
Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorderR S Kahn, G M Asnis, S Wetzler, et al.
Acta Psychiatrica Scandinavica|July 1, 1981
Fluvoxamine and clomipramine in depressed patients. A double-blind clinical studyC J Klok, G J Brouwer, H M van Praag, et al.
Pageof 29